MyozymeActive Ingredient(s): Alglucosidase Alfa
FDA Approved: * April 28, 2006
Pharm Company: * GENZYME
Alglucosidase alfa, sold under the brand name Myozyme among others, is an enzyme replacement therapy (ERT) orphan drug for treatment of Pompe disease (Glycogen storage disease type II), a rare lysosomal storage disorder (LSD). Chemically speaking, the drug is an analog of the enzyme that is deficient in patients affected by Pompe disease, alpha-glucosidase. It is the first drug available to treat this disease. It was approved for medical use in the United... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Myozyme 5 mg/ml Intravenous Injection, Powder, Lyophilized, for SolutionNDC: 58468-0150